AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06618105 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Test Placebo
Description: Matching Placebo of T inhalation aerosol
Study NCT06618105 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reference Placebo
Description: Matching Placebo of R inhalation aerosol
Study NCT06618105 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reference Placebo
Description: Matching Placebo of R inhalation aerosol
Study NCT06618105 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Reference Placebo
Description: Matching Placebo of R inhalation aerosol
Study NCT06618105 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albuterol Sulfate 90 MCG/INHAL Metered Dose Inhaler, 200 Actuations
Description: Albuterol sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of albuterol Base/Inh) (distributed by Teva Pharmaceuticals USA, Inc.)
Study NCT06625450 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tofacitinib
Description: Tofacitinib alone will be continued at a dose of 11 mg once a day
Study NCT06625450 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tofacitinib plus mesalamine
Description: Both tofacitinib 11 mg once a day and mesalamine will be continued
Study NCT06624852 — intervention group
Intervention type: OTHER
Intervention: Screening for coronary artery revascularization based on TMT-ECG
Description: Screening for coronary artery revascularization based on TMT-ECG with and without the assistance of PROPECG-TMT
Study NCT06704269 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: YTB323
Description: CAR-T cell suspension for intravenous infusion
Study NCT06768060 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Short mindfulness-based intervention
Description: The intervention includes a short mindfulness-based intervention with a duration of 5 minutes. It involves a sitting mediation focused on breath adapted from the existing protocols of the Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT). The intervention is audio-guided and will be delivered via headphones.
Study NCT05239910 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenalisib
Description: Tenalisib will be administered orally twice daily in a 21-day cycle for 26 cycles (from cycle 1 to cycle 26), CHOP will be administered for 6 cycles (from Cycle 4 to Cycle 9) on Days 1 to 5 of each cycle.
Study NCT05253547 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy climate-friendly dietary guidelines
Description: Personalised climate-friendly healthy dietary recommendations
Study NCT05253547 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy dietary guidelines
Description: Personalised healthy dietary recommendations
Study NCT02368613 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: DW-3102
Study NCT06150989 — intervention group
Intervention type: BEHAVIORAL
Intervention: Observational Group
Description: All participants will go through a series of lab-based assessments to evaluate their vascular health. These assessments include: heart rhythm/rate, blood pressure, large blood vessel flow, central aortic blood pressure and pulse wave velocity, brain blood flow, carbon dioxide concentration, flow mediated dilation/blood vessel responsiveness, breathing rate, and cerebral vasomotor reactivity. In addition, venous blood sample will be taken to identify biomarkers that are associated with elevating blood pressure and decreasing blood flow.~The 10-day monitoring period includes a wrist-worn activity tracker and a blood pressure monitor bracelet; a smartphone app that will prompt surveys up to 6 times a day to assess behaviors, social/physical context, mood/stress, and experience of racial discrimination/microaggression. Participants will also collect saliva samples on three consecutive days during the 10-day monitoring period.
Study NCT06326710 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth
Description: Participants receive 4 sessions of face-to-face or online delivered workshop on how to use the mobile app Outdoor Rehab-Fit to support their daily PA level. In addition to the workshop, participants have to go to public parks to practice what they have learnt from the mobile app.
Study NCT06326710 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Talk
Description: Participants receive 4 sessions of face-to-face or online delivered health talks on the benefits different types of modified exercises for frail older adults (chair yoga, seated eight-section brocades, Otago and seated multi-component exercise). Each talk has an experiential session.
Study NCT05474729 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: minocycline
Description: minocycline capsule 100mg per day orally
Study NCT02368613 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DW-3102
Study NCT05760664 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group Experimental/Fascial Fitness
Description: Participants will receive twelve treatment sessions, twice a week, for six weeks, lasting 30 minutes per session. The interventions will be applied by a physiotherapist with previous experience and training in the proposed protocols.
Study NCT05760664 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group Sham/Static stretching exercise
Description: Participants will receive twelve treatment sessions, twice a week, for six weeks, lasting 30 minutes per session. The interventions will be applied by a physiotherapist with previous experience and training in the proposed protocols.
Study NCT05760664 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control Group/Placebo
Description: The placebo intervention will be performed using ultrasound turned off in the thoracolumbar region for 15 minutes followed by rest for 15 minutes for 6 weeks, twice a week. Participants will be evaluated on the first day, fourth week and sixth week of intervention.
Study NCT06484101 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 3 x 30 seconds of supramaximal exercise
Study NCT05751070 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bowen Technique
Description: They would be receiving conventional treatment as follow:~Hot pack for 10 minutes TENS for 10 minutes Cervical isometrics 10 reps with 5 sec hold Additionally The Bowen treatment will be 15 to 20 Bowen moves with 2 mins gap between each set for total of 20 mins.
Study NCT05751070 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Graston technique
Description: They would be receiving conventional treatment as follow:~Hot pack for 10 minutes TENS for 10 minutes Cervical isometrics 10 reps with 5 sec hold Additionally The Graston treatment will be by using lubricant on the skin then a stainless steel instrument to relax the fascia and muscles. The frequency of the plastering and friction movements will be applied in 60 repetitions per minute for total of 20 mins.
Study NCT05192590 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Materials and Chronic Disease Management Test (CDMT)
Description: Intervention-1- and Intervention-2-arm participants will receive educational materials duplicating what physicians would receive in the real-world market as they adopt the CDMT technology. These materials are comprised of a PowerPoint presentation.~Intervention 1 participants only will receive the CDMT test results whether they select it or not, and Intervention 2 participants will receive the CDMT test results only if they select it during the second round of case simulations.
Study NCT06047236 — intervention group
Intervention type: OTHER
Intervention: Sampling
Description: Evaluation of immune characteristics by using patient's stool, saliva and blood samples.
Study NCT05384665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: REMIFENTANIL, 5 µg/cc, solution for injection, 0.5 µg/kg, parenteral (intravenous) route, injection delay of 30 seconds, once only
Study NCT05384665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil
Description: SUFENTANIL, 5 µg/cc, solution for injection, 0.2 µg/kg, parenteral (intravenous) route, bolus over 5 seconds, once
Study NCT05384665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: PLACEBO contains 0.9% NaCl, parenteral (intravenous), bolus, one-time
Study NCT05384665 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: PLACEBO contains 0.9% NaCl, parenteral (intravenous), bolus, one-time
Study NCT05699122 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gentle intimate hygiene and skin protective barrier application - Persistent erythema with intact epidermis
Description: Follow-up will be for 4 days, current treatment will be carried out with:~Perform intimate hygiene with warm water (to remove excess feces and urine), apply skin cleanser without rinsing to finish cleaning, apply a thin layer of Dexpanthenol (with each diaper change), apply polymeric spray solution once a day.
Study NCT05699122 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gentle intimate hygiene and skin protective barrier application - Erythema with signs of epidermis loss
Description: Follow-up will be for 4 days, current treatment will be carried out with:~Perform intimate hygiene with warm water (to remove excess feces and urine), applying a leave-in skin cleanser to finish cleaning, applying powdered hydrocolloid powder and removing excess. Afterwards, apply a polymeric spray solution.
Study NCT05699122 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy - Persistent erythema with intact epidermis
Description: Follow-up will be for 4 days, current treatment will be carried out with:~Perform intimate hygiene with warm water (to remove excess feces and urine), apply skin cleanser without rinsing to finish cleaning, apply a thin layer of Dexpanthenol (with each diaper change), apply polymeric spray solution once a day.~It will be associated with the application of Low Intensity Laser Therapy. The entire area affected by DAI will be irradiated with LBI at 1 Joule (J) of energy and with a wavelength of 660nm and 1J with a wavelength of 808nm, which will be applied simultaneously, with a radiance of 20J/cm2 per point, the distance between the stitches will be 1cm long and the application of LLLT will be performed every 24 hours.
Study NCT05699122 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy - Erythema with signs of epidermis loss
Description: Follow-up will be for 4 days, current treatment will be carried out with:~Perform intimate hygiene with warm water (to remove excess feces and urine), applying a leave-in skin cleanser to finish cleaning, applying powdered hydrocolloid powder and removing excess. Afterwards, apply a polymeric spray solution.~It will be associated with the application of Low Intensity Laser Therapy. The entire area affected by DAI will be irradiated with LBI at 1 Joule (J) of energy and with a wavelength of 660nm and 1J with a wavelength of 808nm, which will be applied simultaneously, with a radiance of 20J/cm2 per point, the distance between the stitches will be 1cm long and the application of LLLT will be performed every 24 hours.
Study NCT06015555 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TAMO
Description: TAMO therapy
Study NCT06015555 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Postural Control exercises
Description: Postural Control exercises
Study NCT05194189 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: 12 g vitamin C (48 ml) will be intravenously injected by a infusion pump every 12 h for 4 days or at ICU discharge
Study NCT05194189 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 5% glucose injection
Description: 5% glucose solution 48 ml every 12 h for 4 days or at ICU discharge.
Study NCT05670002 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Milk supplement
Description: Children will take the milk supplement for a period of 6 months. During the intervention, anthropometry data, Zinc Protoporphyrin levels, dietary intake, any illness will be recorded.
Study NCT06149546 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Control
Description: * High protein, high energy diet~* Fish oil supplement (ProSure®)~* Pancreatic Enzymes (Creon®)~* A daily individualised step target (10% above your own baseline)~* Four scheduled appointments with a dietitian
Study NCT06149546 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Intervention
Description: * High protein, high energy diet~* Fish oil supplement (ProSure®)~* Pancreatic Enzymes (Creon®)~* A daily individualised step target (10% above your own baseline)~* Seven scheduled appointments with a dietitian~* Six scheduled appointments with a physiotherapist
Study NCT06002191 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Flourish
Description: Flourish is a text messaging program that aims to improve coping following cyberbullying and reduce suicide risk among youth.
Study NCT06002191 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires of Online Experiences
Description: Adolescents will receive brief questionnaires related to their online experiences and the impact those experiences have had on their stress level.
Study NCT06002191 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaires of Online Experiences
Description: Adolescents will receive brief questionnaires related to their online experiences and the impact those experiences have had on their stress level.
Study NCT05297643 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ekstracorporeal Shock Wave Therapy (ESWT)
Description: Extracorporeal Shock Wave Therapy (ESWT); It is a treatment method in which high-intensity pressure waves are applied to the desired point in the body. It has been used in the treatment of kidney stones in previous years, and changes in bone tissue have been observed (12). Today, it is used in musculoskeletal system diseases such as plantar fasciitis, epicondylitis, achiltendinitis, osteoarthritis
Study NCT05297643 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: complex decongestive therapy
Description: Complex decongestive therapy consists of manual lymphatic degeneration, compression therapy, skin care and remedal exercise.
Study NCT05297643 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: complex decongestive therapy
Description: Complex decongestive therapy consists of manual lymphatic degeneration, compression therapy, skin care and remedal exercise.
Study NCT04995237 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PPP
Description: Participants will be provided with a weekly bag of produce, information about how to cook the produce, assistance in setting quality of life goals, and individualized teaching to support meeting participant's set goals.
Study NCT04183907 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transform
Description: The Partner, Blue Mesa Health, has developed a lifestyle intervention program for pre-diabetics that aims to prevent or delay the onset of type 2 diabetes through incremental changes to health behaviours. Transform is based on the CDC's National Diabetes Prevention Program (DPP). Blue Mesa Health adapted the National DPP into a digital experience by combining the use of technology- an app, wearable activity trackers (Fitbit) and digital scales- with the professional guidance of remote health coaches.~It is a 6-month intervention that helps individuals establish healthier lifestyle habits. Each participant strives to achieve 2 primary goals:~Attaining 5 to 7 percent weight loss from their starting bodyweight Engaging in at least 150 minutes of weekly physical activity
Study NCT05041816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Focal vibration therapy
Description: Myovolt delivers vibration with a frequency between 60-300 Hz, and acceleration force between 1.8g to 19.1g peak to peak. Myovolt intensity will be set to \~up to 2X the participant's initial Myovolt perception threshold (however, the maximum intensity will be limited to 19.1g which is the maximum intensity the device can deliver). If the stimulation does not feel strong, the participant will be asked to manually increase the intensity until it feels strong but comfortable.
Study NCT05521555 — intervention group
Intervention type: PROCEDURE
Intervention: Total knee arthroplasty
Description: First intention total knee arthroplasty
Study NCT05073341 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Nurse-led family intervention
Description: Nurse-led family intervention having three components first is infarmation about the patient's condition and guidance will be given to solve there queries and the emotional support will be given to the primary caregivers of CLD patient's admitted in HDU
Study NCT05073341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse-led family intervention
Description: Nurse-led family intervention having three components first is infarmation about the patient's condition and guidance will be given to solve there queries and the emotional support will be given to the primary caregivers of CLD patient's admitted in HDU
Study NCT04458116 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Curcumin
Description: Participants will receive 1.5 grams of turmeric 95% curcumin for 1 month (3 capsules / day containing 500mg each for 4 weeks).
Study NCT04458116 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Curcumin
Description: Participants will receive 1.5 grams of turmeric 95% curcumin for 1 month (3 capsules / day containing 500mg each for 4 weeks).
Study NCT04791202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextrose
Description: See arm descriptions
Study NCT04791202 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolone Acetate 40 MG/ML
Description: See arm descriptions
Study NCT05667701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Soy isoflavone
Description: Soy isoflavone supplement (Novasoy) that contains isoflavones (genistein, daidzein, glycetein) given at a dose of genistein aglycone equivalents to provide the genistein dosing of 22.6 mg/day for children aged 2-10 months, and 30.3 mg/day children aged 10-24 months
Study NCT05667701 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: matching placebo
Description: A matching placebo also administered twice daily.
Study NCT00673751 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GLP-2
Description: 450 nmol subcutaneous
Study NCT00673751 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT05498103 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methazolamide 25 MG
Description: 25 mg tablets
Study NCT05498103 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methazolamide 50 MG
Description: 50 mg tablets
Study NCT06247007 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Description: LI-4, LI-11, GV-14, GV-20 acupuncture points were needled bilaterally.
Study NCT05019196 — intervention group
Intervention type: DEVICE
Intervention: GE 3.0T MRI
Description: using GE 3.0T MRI to obtain anatomical and functional MR images and DTI images
Study NCT05314842 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Formocresol
Description: dressing agents in pulpotomized primary molas using formocresol in cariously exposed vital primary molars
Study NCT05314842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Premixed bioceramic MTA
Description: dressing agents in pulpotomized primary molas using premixed bioceramic MTA in cariously exposed vital primary molars
Study NCT05516017 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vestibular Electrical Stimulator and Pinhole Glasses
Description: It is applied with a vestibular electrical stimulation device for 20 msec with 2 Hz, 1-4 mA, 1 mA increments. Very high frequencies can cause auditory perceptions such as 0.5 - 20 kHz, should be avoided.~The pinhole glasses are made of 2 pieces of opaque black plastic material with a total of 113 holes on each side. The opaque black plastic is 1.7 mm thick, 4.5 cm wide, and 5.5 cm long.~The holes in the opaque black material are arranged horizontally in 11 rows from top to bottom. The diameter of each hole is 1.1 mm, the horizontal distance of the holes from each other is 4.5 mm, and the vertical distance is 3.5 mm.
Study NCT05516017 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vestibular Electrical Stimulator
Description: It is applied with a vestibular electrical stimulation device for 20 msec with 2 Hz, 1-4 mA, 1 mA increments. Very high frequencies can cause auditory perceptions such as 0.5 - 20 kHz, should be avoided.
Study NCT06624943 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: biosimilar insulin glargine
Description: Once daily injection of biosimilar insulin glargine via reusable pen
Study NCT05694897 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector spinae block using bupivacaine 0.25% and magnesium sulfate
Description: After induction of general anesthesia the patients will be flipped to the prone position and ESP block was performed using, a high frequency linear ultrasound probe placed longitudinally 2 to 3 cm lateral to the 10th thoracic vertebrae, and the trapezius and erector Spinae muscles identified.~An 18-G Tuohy needle passed along the plane of the transducer until its tip hit the transverse process of T10; the needle was then withdrawn slightly.~Total volume of 25 ml was injected including 20 mL 0.25% bupivacaine plus 3.75 ml NS and 125 mg MgSO4 (1.25ml).